Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends
XTalks
AUGUST 2, 2023
5) Ibrance (palbociclib) Ibrance is a chemotherapy drug indicated for hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. Veklury generated a revenue of $3.91 Teva Pharmaceutical Industries Ltd. It is one of the largest generic drug manufacturers in the world.
Let's personalize your content